BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 08/08/1994

Opportunity for Exclusive or Non-Exclusive Licensing: Prostratin, a Novel Anti-viral Compound Useful in the Treatment of Acquired Immunodeficiency Syndrome (AIDS)

The National Institutes of Health (NIH) seeks a licensee to develop prostratin, a compound with strong antiviral activity against HIV-1, for the treatment of HIV infection and AIDS.

Source: Federal Register — Health and Human ServicesOpen original release →